Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.

Journal of aerosol medicine and pulmonary drug delivery - 1 Oct 2015

Sahota Jaspreet Singh, Smith Claire Mary, Radhakrishnan Priya, Winstanley Craig, Goderdzishvili Marina, Chanishvili Nina, Kadioglu Aras, O'Callaghan Chris, Clokie Martha Rebecca Jane

Abstract excerpt

BACKGROUND: The rise in antibiotic-resistant Pseudomonas aeruginosa and the considerable difficulty in eradicating it from patients has re-motivated the study of bacteriophages as a therapeutic option. For this to be effective, host range and viability following nebulization need to be assessed. Host-range has not previously been assessed for the Liverpool Epidemic Strain (LES) isolates that are the most common...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Source

Identifiers

PMID: 25714328
DOI: 10.1089/jamp.2014.1172

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.PMID 25714328Read ↗

Pseudomonas aeruginosa Bacteriophages and Their Clinical ApplicationsSemantic proximity Read ↗

Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail FormulationSemantic proximity Read ↗

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airwaysSemantic proximity Read ↗

Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative ReviewSemantic proximity Read ↗

Reduced prevalence of phage defense systems in Pseudomonas aeruginosa strains from cystic fibrosis patientsSemantic proximity Read ↗

Reduced prevalence of phage defense systems in <i>Pseudomonas aeruginosa</i> strains from Cystic Fibrosis PatientsSemantic proximity Read ↗

Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosisSemantic proximity Read ↗

Evaluation of Phage Therapy for Pulmonary Infection of Mouse by Liquid Aerosol-Exposure Pseudomonas aeruginosaSemantic proximity Read ↗

Expanding Clinical Phage Microbiology: Simulating Phage Inhalation for Respiratory Tract InfectionsSemantic proximity Read ↗

Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?Semantic proximity Read ↗

Host species background, defence systems, and phage tail gene architecture shape phage infectivity in cystic fibrosis-associated AchromobacterSemantic proximity Read ↗

Phage-phage competition and biofilms reduce the efficacy of a combination of two virulent bacteriophages against <i>Pseudomonas aeruginosa</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.